Gaurav Dwivedi

Employment

• Merck & Co., Inc., Rahway, NJ, USA Director, QSP
  2025 - Present
• Sarepta Therapeutics (United States) Director, QSP & Data Analytics
  2024 - 2025
• Takeda Pharmaceutical Company Associate Scientific Director
  2020 - 2024
• PricewaterhouseCoopers LLP US
  2007 - 2020

Education

• Georgia Institute of Technology PhD
  2008 - 2014
• Indian Institute of Technology Guwahati BTech
  2004 - 2008

Projects & Funding

Projects & funding information is unavailable.

Publications (12)

• Optimization of nutritional strategies using a mechanistic computational model in prediabetes: Application to the J-DOIT1 study data
  PLOS ONE 2023 DOI: 10.1371/journal.pone.0287069
  +Save
• Creating digital twins at scale (patent pending)
  2021
  +Save
• System and method for physiological health simulation
  2019
  +Save
• A long-term mechanistic computational model of physiological factors driving the onset of type 2 diabetes in an individual
  PLOS ONE 2018 DOI: 10.1371/journal.pone.0192472
  +Save
• Dynamic Redox Regulation of IL-4 Signaling
  PLOS Computational Biology 2015 DOI: 10.1371/journal.pcbi.1004582
  +Save
• A Multiscale Model of Interleukin-6–Mediated Immune Regulation in Crohn’s Disease and Its Application in Drug Discovery and Development
  CPT: Pharmacometrics & Systems Pharmacology 2014 DOI: 10.1038/psp.2013.64
  +Save
• Modeling, Nonequilibrium Redox Systems
  Encyclopedia of Systems Biology 2013 DOI: https://doi.org/10.1007/978-1-4419-9863-7_1160
  +Save
• System Identification in Signal Transduction, Experimental Perturbations
  Encyclopedia of Systems Biology 2013 DOI: https://doi.org/10.1007/978-1-4419-9863-7_1159
  +Save
• Quantification of degeneracy in biological systems for characterization of functional interactions between modules
  Journal of Theoretical Biology 2012 DOI: 10.1016/j.jtbi.2012.02.020
  +Save
• Systemic Redox Regulation of Cellular Information Processing
  Antioxidants & Redox Signaling 2012 DOI: 10.1089/ars.2011.4034
  +Save